In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects

Medical Mycology

Volumn 41, Issue 4, 2003, Pages 301-307

  Vitale, R G ^a,b   De Hoog, G S ^b,c   Verweij, Paul E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Antifungals; Black yeasts; Exophiala; PAFE

Indexed keywords

5 FLUOCYTOSINE; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EXOPHIALA SPINIFERA; FUNGAL STRAIN; IN VITRO STUDY; INHIBITION KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOMES RESEARCH; STRAIN DIFFERENCE; TEMPERATURE MEASUREMENT; YEAST;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ENVIRONMENTAL MICROBIOLOGY; EXOPHIALA; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MYCOSES; NAPHTHALENES;

CHAETOTHYRIALES; EXOPHIALA; EXOPHIALA SPINIFERA;

EID: 0041823862     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693780310001600822     Document Type: Article

References (35)

1. De Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of Clinical Fungi. Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili. 2nd edn. Utrecht/Reus, 2000: 1126.
2. Nielsen HS Jr., Conant NF. A new human pathogenic Phialophora. Sabouraudia 1968; 6: 228-231.
3. Rajam RV, Kandhari KC, Thirumalachar M. Chromoblastomycosis caused by a rare yeast-like dematiaceous fungus. Mycopath Mycol Appl 1958; 9: 5-19.
4. Dai WL, Wang DL, Ren ZF, Li RY, Wang JZ. First case of systemic phaeohyphomycosis caused by Exophiala spinifera in China. Chin J Derm 1987; 20: 13-15.
5. Padhye AA, Ajello L, Chandler FW, et al. Phaeohyphomycosis in El Salvador caused by Exophiala spinifera. Am J Trop Med Hyg 1983; 32: 799-803.
6. De Hoog GS, Poonwan N, Gerrits Van Den Ende AHG. Taxonomy of Exophiala spinifera and its relationship to E. jeanselmei. Stud Mycol 1999; 43: 133-142.
7. NCCLS. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi; Proposed Standard. Document M-38P: National Committee for Clinical Laboratory Standards, Wayne, PA, 1998.
8. Denning DW, Radford SA, Oakley KL, et al. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 1997; 40: 401-414.
9. Vitale RG, Mouton JW, Afeltra J, Meis JF, Verweij PE. Method for measuring postantifungal effect in Aspergillus species. Antimicrob Agents Chemother 2002; 46: 1960-1965.
10. Craig WA, Gudmunsson S. Postantibiotic effect. In: Victor Lorian ME (ed.). Antibiotics in Laboratory Medicine, 3rd edn. Baltimore: Williams & Wilkins, 1991: 403-431.
11. McGinnis MR, Pasarell L. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J Clin Microbiol 1998; 36: 2353-2355.
12. Meletiadis J, Meis JF, De Hoog GS, Verweij PE. In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs. Mycoses 2000; 43: 309-312.
13. Vitale RG, De Hoog GS. Molecular diversity and new species in the Exophiala spinifera clade. Med Mycol 2002; 40: 545-556.
14. Chermette R, Ferreiro L, De Bièvre C, et al. Exophiala spinifera nasal infection in a cat and a review of feline phaeohyphomycosis. J Mycol Méd 1997; 7: 149-158.
15. De Hoog GS. Significance of fungal evolution for the understanding of their pathogenicity, illustrated with agents of phaeohyphomycosis. Mycoses 1997; 40: 5-8.
16. De Hoog GS. Risk assessment of fungi reported from humans and animals. Mycoses 1996; 39: 407-417.
17. Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: Case report and review. Clin Infect Dis 1997; 24: 369-374.
18. Da Silva Lacaz C, Porto E, De Andrade JG, Telles Filho F. Feohifomycose disseminada por Exophiala spinifera. An Bras Derm 1984; 59: 238-243.
19. Dieye M, Dieng MT, Raphenon G, Develoux M, Guého E. Premier cas de chromoblastomycose au Sénégal: Isolement de Exophiala spinifera chez un patient lépromateux. Abstr Réun Soc Fr Mycol Méd 1998; 5.
20. Wang D, Li R, Wang X, Dai W. Studies on three strains of Exophiala spinifera. Acta Mycol Sin 1987; 6: 229-232.
21. Mirza SH, Hannan A, Ahmad A, Ahmad M. Subcutaneous phaeohyphomycosis. J Infect 1993; 27: 75-78.
22. Campos-Takaki GM, Jardim ML. Report of chronic subcutaneous abscesses caused by Exophiala spinifera. Mycopathologia 1994; 127: 73-76.
23. Lacroix C, Barrazza V, Levy A, et al. Lésions cutanées végétantes à Exophiala spinifera chez un patient immunodéprimé. Abstr Réun Soc Fr Mycol Méd 1998; 25.
24. Gold WL, Vellend H, Salit IE, et al. Successful treatment of systemic and local infections due to Exophiala species. Clin Infect Dis 1994; 19: 339-341.
25. Barba-Gomez JF, Mayorga J, McGinnis MR, Gonzalez-Mendoza A. Chromoblastomycosis caused by Exophiala spinifera. J Am Acad Dermatol 1992; 26: 367-370.
26. Padhye AA, Hampton AA, Hampton MT, et al. Chromoblastomycosis caused by Exophiala spinifera. Clin Infect Dis 1996; 22: 331-335.
27. Padhye AA, Kaplan W, Neuman MA, Case P, Radcliffe GN. Subcutaneous phaeohyphomycosis caused by Exophiala spinifera. Sabouraudia 1984; 22: 493-500.
28. Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990; 23: 577-586.
29. Kotylo PK, Israel KS, Cohen JS, Bartlett MS. Subcutaneous phaeohyphomycosis of the finger caused by Exophiala spinifera. Am J Clin Pathol 1989; 91: 624-627.
30. Negroni R, Robles AM, Arechavala A. Disseminated phaeohyphomycosis caused by Exophiala spinifera. Revta Argent Micol 1995; 18: 2-10.
31. Kettlewell P, McGinnis MR, Wilkinson GT. Phaeohyphomycosis caused by Exophiala spinifera in two cats. J Med Vet Mycol 1989; 27: 257-264.
32. Ernst EJ, Klepser ME, Pfaller MA. Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans. Antimicrob Agents Chemother 2000; 44: 1108-1111.
33. Turnidge JD, Gudmundsson S, Vogelman B, Craig WA. The postantibiotic effect of antifungal agents against common pathogenic yeasts. J Antimicrob Chemother 1994; 34: 83-92.
34. Scalarone GM, Mikami Y, Kurita N, Yazawa K, Miyaji M. The postantifungal effect of 5-fluorocytosine on Candida albicans. J Antimicrob Chemother 1992; 29: 129-136.
35. Meletiadis J, Meis JF, Mouton JW, Verweij PE. Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol 2001; 39: 478-484.